With the help of professional drug treatment programs, a large number of addicts have learned to live meaningful, drug-free lives. Relapse rates among recovering opiate addicts are as high as 90 percent, according to a study published in the Irish Medical Journal; however, addicts in this study who completed an inpatient treatment program were more likely to avoid relapse and remain drug-free.
This subtype represents only 9 percent of U.S. alcoholics, yet more members of this group seek treatment (almost two-thirds) than any other category. Chronic, severe alcoholics have fought a long battle with this disease, and most are now middle-aged. The majority of people in this group have a co-occurring psychiatric disorder, such as major depression, bipolar disorder, or anxiety disorders. Many also abuse other drugs, like cocaine or opiates.
We respect that your time and energy is limited. You want to make up for lost time with your friends and family, and commit yourself to your responsibilities. You are more than your past addiction, and while it is important to maintain strong bonds with the recovery community, it should no longer take up your whole life. Searidge’s aftercare program offers a variety of options that will work with your specific daily responsibilities and needs.
At this stage, you will have developed a problem with alcohol and will be drinking out of habit than choice. Your use may be starting to have an impact on other aspects of your life and you might be noticing problems with your moods and sleeping patterns. Nevertheless, you are probably still at the stage where you are enjoying alcohol and believe that it is making your life better.
Cognitive–Behavioral Therapy can take place one-on-one with a therapist or in small groups. This form of therapy is focused on identifying the feelings and situations (called “cues”) that lead to heavy drinking and managing stress that can lead to relapse. The goal is to change the thought processes that lead to excessive drinking and to develop the skills necessary to cope with everyday situations that might trigger problem drinking.
Note: These PET scans compare the brain of an individual with a history of cocaine use disorder (middle and right) to the brain of an individual without a history of cocaine use (left). The person who has had a cocaine use disorder has lower levels of the D2 dopamine receptor (depicted in red) in the striatum one month (middle) and four months (right) after stopping cocaine use compared to the non-user. The level of dopamine receptors in the brain of the cocaine user are higher at the 4-month mark (right), but have not returned to the levels observed in the non-user (left).
Another example of CBT would be teaching the patient how to respond to the triggers that might once have tempted them to drink. It could be as straightforward as learning to decline an invitation to consume an alcoholic beverage. For a casual drinker, this is not an issue at all; for someone who had an intense psychological desire to drink, saying “no” can seem like the hardest challenge in the world, but that is how CBT can help turn a recovering addict’s life around.
Quality of life improvement. Drug rehab is about helping the patient learn how to avoid relapse on an ongoing basis, but it should also be about helping patients to improve their daily experience. This happens when they are given the assistance they need to handle the other issues in their life that may be diminishing their ability to remain clean and sober. Health problems, legal issues, family problems – all these and more should be addressed on an as-needed basis at an effective addiction treatment program.
“Residential rehab” and “inpatient rehab” are two phrases often used interchangeably, as they both follow medical detox, and accommodate the physical and psychological needs of individuals in recovery. They also both involve full-time treatment at a rehab facility, allowing for 24-hour monitoring. However, one major difference between the two forms of treatment is the length of the program.
You won't be judged. It’s probably difficult for you to talk about your drinking, because you're afraid nobody will understand you and they'll criticize you. So you bottle everything up inside, which makes you feel more guilt and shame, and makes you want to drink even more. The people at a self-help group won't judge you because they've heard it all before. They've done it all before. They know you're not crazy. You're addicted.
Cost may be a factor when selecting a treatment approach. Evaluate the coverage in your health insurance plan to determine how much of the costs your insurance will cover and how much you will have to pay. Ask different programs if they offer sliding scale fees — some programs may offer lower prices or payment plans for individuals without health insurance.
When surveying populations based on gender in those ages 12 and older, it was observed that males had a higher substance dependence rate than females. However, the difference in the rates aren't apparent until after age 17. The Drug and Alcohol Dependence reports that older adults abuse drugs and alcohol at a rate of 15-20%. It's estimated that 52 million Americans beyond 12 years old have abused a substance.
When a person who is dependent on sleeping pills tries to quit cold turkey, their body may experience withdrawal. Symptoms of withdrawal can be uncomfortable, so it is best to go through the process at a medical detox center. Further treatment at an inpatient rehab center or outpatient program can address the psychological impact of an addiction to sleeping pills.
Drug addiction is a complex neurobiological disease that requires integrated treatment of the mind, body, and spirit. It is considered a brain disease because drugs change the brain — they change its structure and how it works. Without treatment, these brain changes can be long-lasting. Addiction is chronic, it is progressive, and if left untreated, it can be fatal.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)